STRATA Skin Sciences Files 8-K
Ticker: SSKN · Form: 8-K · Filed: Mar 27, 2024 · CIK: 1051514
| Field | Detail |
|---|---|
| Company | Strata Skin Sciences, Inc. (SSKN) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, financial-reporting
TL;DR
STRATA Skin Sciences dropped an 8-K, likely with financial updates. Keep an eye on this.
AI Summary
STRATA Skin Sciences, Inc. filed an 8-K on March 27, 2024, reporting on its Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This 8-K filing signals that STRATA Skin Sciences, Inc. is providing important updates regarding its financial condition and operations to the public, which is crucial for investors to monitor.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not contain information that inherently suggests immediate high risk.
Key Players & Entities
- STRATA Skin Sciences, Inc. (company) — Registrant
- MELA SCIENCES, INC. (company) — Former Company Name
- ELECTRO OPTICAL SCIENCES INC (company) — Former Company Name
- March 27, 2024 (date) — Date of Report
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text of the 8-K filing does not contain specific financial figures or detailed operational updates. It only lists the categories of information being reported: Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on March 27, 2024.
What is the principal executive office address for STRATA Skin Sciences, Inc.?
The principal executive offices of STRATA Skin Sciences, Inc. are located at 5 Walnut Grove Drive, Suite 140, Horsham, Pennsylvania 19044.
Has STRATA Skin Sciences, Inc. operated under any former names?
Yes, STRATA Skin Sciences, Inc. previously operated under the names MELA SCIENCES, INC. and ELECTRO OPTICAL SCIENCES INC.
What is the SIC code for STRATA Skin Sciences, Inc.?
The Standard Industrial Classification (SIC) code for STRATA Skin Sciences, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 685 words · 3 min read · ~2 pages · Grade level 9.3 · Accepted 2024-03-27 16:44:24
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share SSKN The NASDAQ
Filing Documents
- ef20025035_8k.htm (8-K) — 28KB
- ef20025035_ex99-1.htm (EX-99.1) — 304KB
- image00001.jpg (GRAPHIC) — 3KB
- 0001140361-24-015650.txt ( ) — 493KB
- sskn-20240327.xsd (EX-101.SCH) — 4KB
- sskn-20240327_lab.xml (EX-101.LAB) — 21KB
- sskn-20240327_pre.xml (EX-101.PRE) — 16KB
- ef20025035_8k_htm.xml (XML) — 4KB
02
Item 2.02. Results of Operations and Financial Condition. On March 27, 2024, STRATA Skin Sciences, Inc. (the "Company") issued a press release announcing its results of operations for the fourth fiscal quarter and full year ended December 31, 2023 . The full text of such press release is furnished as Exhibit 99.1 to this report. The information set forth under this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
01
Item 7.01. Regulation FD Disclosure. On March 27, 2024, STRATA Skin Sciences, Inc. (the "Company") issued a press release announcing its results of operations for the fourth fiscal quarter and full year ended December 31, 2023. The full text of such press release is furnished as Exhibit 99.1 to this report. The information set forth under this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. The following press release is furnished as an exhibit to this Current Report on Form 8-K pursuant to Item 2.02 and shall not be deemed to be "filed": 99.1 Press Release dated March 27, 2024 issued by STRATA Skin Sciences, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STRATA SKIN SCIENCES, INC. Date: March 27, 2024 By: /s/ Christopher Lesovitz Christopher Lesovitz Chief Financial Officer